Evidence map›Paper›PMID 29427404›Full record

ArticleXenotransplantation2018

Interleukin-8 mediates neutrophil-endothelial interactions in pig-to-human xenogeneic models.

Beth M French, Selin Sendil, Krishna Mohan Sepuru, Jolene Ranek, Lars Burdorf, Donald Harris, Emily Redding, Xiangfei Cheng, Christopher T Laird, Yuming Zhao and 4 more

Open access · greenAbstract read
In one paragraph

Article in Xenotransplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Gut microbes · 2026
    Review
  2. Review
  3. Review
  4. Pig Lung Xenotransplantation: Barriers on the Road to Clinical Translation.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  5. Article
  6. Article
  7. Pig heart and lung xenotransplantation: Present status.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Beth M FrenchDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-6493-318X
Selin SendilDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-3989-9458
Krishna Mohan SepuruDepartment of Biochemistry and Molecular Biology, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0002-3675-6294
Jolene RanekDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Lars BurdorfDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Donald HarrisDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-5059-5597
Emily ReddingDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Xiangfei ChengDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-8247-9868
Christopher T LairdDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-0733-8720
Yuming ZhaoDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Benjamin CerelDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-8064-1101
Krishna RajarathnamDepartment of Biochemistry and Molecular Biology, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0002-0077-700X
Richard N PiersonDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-9862-2195
Agnes M AzimzadehDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-0761-6353
University of Maryland, Baltimore · USThe University of Texas Medical Branch at Galveston · US

Funding

Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammationU19AI090959 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MOHIUDDIN, MUHAMMAD M · 2010 to 2024
$26.3M
Therapeutic assessment of synthetic heparin sulfates in transplantation modelsP01HL107152 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DESAI, UMESH RAMANLAL · 2011 to 2017
$15.8M
Vascular Biology Training ProgramT32HL007698 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Rosemary A Kozar, Dudley K. Strickland · 1991 to 2026
$8.7M
NHLBI NIH HHS P01 HL107152NHLBI NIH HHS T32 HL007698NIAID NIH HHS U19 AI090959
6 · The paper itself

Abstract

backgroundHuman neutrophils are sequestered by pig lung xenografts within minutes during ex vivo perfusion. This phenomenon is not prevented by pig genetic modifications that remove xeno-antigens or added human regulatory molecules intended to down-regulate activation of complement and coagulation pathways. This study investigated whether recipient and donor interleukin-8 (IL-8), a chemokine known to attract and activate neutrophils during inflammation, is elaborated in the context of xenogeneic injury, and whether human or pig IL-8 promote the adhesion of human neutrophils in in vitro xenograft models.

methodsPlasma levels of pig, human or non-human primate (NHP) IL-8 from ex vivo pig lung perfusion experiments (n = 10) and in vivo pig-to-baboon lung transplantation in baboons (n = 22) were analysed by ELISA or Luminex. Human neutrophils stimulated with human or pig IL-8 were analysed for CD11b expression, CD18 activation, oxidative burst and adhesion to resting or TNF-activated endothelial cells (EC) evaluated under static and flow (Bioflux) conditions. For some experiments, human neutrophils were incubated with Reparixin (IL-8/CXCL8 receptor blocker) and then analysed as in the in vitro experiments mentioned above.

resultsPlasma levels of pig IL-8 (~6113 pg/mL) increased more than human (~1235 pg/mL) between one and four hours after initiation of ex vivo lung perfusion. However, pig IL-8 levels remained consistently low (<60 pg/mL) and NHP IL-8 plasma levels increased by ~2000 pg/mL after four hours in a pig-to-baboon lung xenotransplantation. In vitro, human neutrophils' CD11b expression, CD18 activation and oxidative burst all increased in a dose-dependent manner following exposure to either pig or human IL-8, which also were associated with increased adhesion to EC in both static and flow conditions. Reparixin inhibited human neutrophil activation by both pig and human IL-8 in a dose-dependent fashion. At 0.1 mg/mL, Reparixin inhibited the adhesion of IL-8-activated human neutrophils to pAECs by 84 ± 2.5%.

conclusionsPig IL-8 increased in an ex vivo model of pig-to-human lung xenotransplantation but is not detected in vivo, whereas human or NHP IL-8 is elevated to a similar degree in both models. Both pig and human IL-8 activate human neutrophils and increase their adhesion to pig aortic ECs, a process significantly inhibited by the addition of Reparixin to human neutrophils. This work implicates IL-8, whether of pig or human origin, as a possible factor mediating in lung xenograft inflammation and injury and supports the evaluation of therapeutic targeting of this pathway in the context of xenotransplantation.

Indexed as

Transplantation, HeterologousAnimalsChemokinesEndothelial CellsHeterograftsHumansInflammationInterleukin-8NeutrophilsPapioSwineChemokinesInterleukin-8cell adhesionchemokinesendothelial cellsinterleukin-8lungneutrophilsxenotransplantation

Identifiers

PMID29427404
PMCPMC5899681
OpenAlexW2804419114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.